Westaim Corp.

NUCRYST Announces the Completion of the Sale of its Acticoat Business.
Biotech Week; 1/6/2010; 696 words; ...NUCRYST Pharmaceuticals Corp. ("Nucryst") (TSX...Nucryst Pharmaceuticals Corp.). The meeting was...formed subsidiary of The Westaim Corporation ("Westaim...shareholders other than Westaim will receive for each...Nucryst Pharmaceuticals Corp. This article was prepared...

FORM 8-K: NUCRYST PHARMACEUTICALS ANNOUNCES DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS, ELECTION OF DIRECTORS
US Fed News Service, Including US State News; 12/22/2009; 614 words; ...NUCRYST PHARMACEUTICALS CORP., Princeton, N.J., files...charter is NUCRYST PHARMACEUTICALS CORP. State of Incorporation: Alberta...2009, NUCRYST Pharmaceuticals Corp. (the "Company") has agreed...amalgamation with an affiliate of the Westaim Corporation (the "Amalgamation...

NUCRYST Announces Special Meeting of Shareholders.
Biotech Week; 12/9/2009; 714 words; ...the NUCRYST Pharmaceuticals Corp., NUCRYST Pharmaceuticals...also Nucryst Pharmaceuticals Corp.). If the first special resolution...wholly-owned subsidiary of The Westaim Corporation substantially on...Treatment, Nucryst Pharmaceuticals Corp. This article was prepared...

NUCRYST announces 2009 third quarter financial results.(Financial report)
Biotech Week; 12/2/2009; 1092 words; ...NUCRYST Pharmaceuticals Corp., a developer and manufacturer...Nucryst Pharmaceuticals Corp.). For the quarter...amalgamation agreement with The Westaim Corporation ("Westaim...shareholders other than Westaim will receive for each...Nucryst Pharmaceuticals Corp. This article was ...

Westaim announces 2009 third quarter results.(Financial report)
Biotech Week; 12/2/2009; 893 words; ...NUCRYST Pharmaceuticals Corp., was $24.2 million. Westaim recently announced the...wealth preservation. Westaim holds an approximate...NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim's common shares are...